Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study
- PMID: 35313216
- PMCID: PMC8935504
- DOI: 10.1016/j.ebiom.2022.103951
Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study
Abstract
Background: We comprehensively analyzed the global burdens and trends in incidence and mortality of tracheal, bronchus, and lung (TBL) cancer among subgroups of distinctive ages and genders.
Methods: We retrieved incidence and mortality rates of lung cancer in 2020 from the GLOBOCAN database among 185 countries. The incidence and mortality age-standardized rates (ASRs) were mostly obtained from Cancer Incidence in Five Continents and World Health Organization mortality database, respectively. The joinpoint regression analysis has been conducted to evaluate the average annual percentage change of incidence and mortality in recent years.
Findings: Trends in the incidence and mortality were decreasing among men in most countries, whereas the trends were increasing among women in some regions. As for mortality, most countries had a decreasing trend in mortality among males, but increasing trends were observed in more than half of countries among females. Furthermore, the majority of countries showed a significant decrease in incidence among males (AAPCs, -0·34 to -6·53), whereas most countries had a significant increase among females (AAPCs, 9·39 to 0·6), especially in European countries. In addition, a more drastic decrease was identified in the trends of the incidence among young people. 33 countries had a drastic decrease among males, especially in countries in Europe (AAPCs, -0·93 to -11·71). And 15 countries showed a significant decrease in incidence among young women (AAPCs, -0·94 to -9·35).
Interpretation: Decreasing incidence and mortality trends were identified in TBL cancer, particularly among all-age men and women younger than 50 years old. But some other groups of individuals showed an opposite trend, such as women in European countries. More preventive interventions are required for the specific populations.
Funding: A full list of funding bodies that contributed to this study can be found in the Acknowledgements section.
Keywords: ASR; Epidemiology; Global; Lung cancer; Trend analysis.
Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of interests All the authors have declared no conflicts of interest and completed the ICMJE forms.
Figures





Similar articles
-
Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer.Gastroenterology. 2021 Feb;160(3):744-754. doi: 10.1053/j.gastro.2020.10.007. Epub 2020 Oct 13. Gastroenterology. 2021. PMID: 33058868
-
Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.J Hematol Oncol. 2020 Jul 20;13(1):98. doi: 10.1186/s13045-020-00915-0. J Hematol Oncol. 2020. PMID: 32690044 Free PMC article.
-
Global burden and temporal trends in incidence and mortality of oesophageal cancer.J Adv Res. 2023 Aug;50:135-144. doi: 10.1016/j.jare.2022.10.007. Epub 2022 Oct 20. J Adv Res. 2023. PMID: 36272715 Free PMC article.
-
International variations and trends in renal cell carcinoma incidence and mortality.Eur Urol. 2015 Mar;67(3):519-30. doi: 10.1016/j.eururo.2014.10.002. Epub 2014 Oct 16. Eur Urol. 2015. PMID: 25449206 Review.
-
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Respir Med. 2021 Sep;9(9):1030-1049. doi: 10.1016/S2213-2600(21)00164-8. Epub 2021 Aug 16. Lancet Respir Med. 2021. PMID: 34411511 Free PMC article.
Cited by
-
Differences in the incidence and mortality of tracheal, bronchus, and lung cancer between the Global Cancer Observatory 2022 and the Global Burden of Disease 2021.J Natl Cancer Cent. 2025 Feb 27;5(3):267-277. doi: 10.1016/j.jncc.2025.02.004. eCollection 2025 Jun. J Natl Cancer Cent. 2025. PMID: 40693229 Free PMC article.
-
Capsule Endoscopy-Based Diagnosis of Lung Squamous Cell Carcinoma Associated with Abdominal Pain and Metastasis to Small Intestine: A Case Report.Case Rep Oncol. 2023 Feb 20;16(1):102-108. doi: 10.1159/000529060. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 36824988 Free PMC article.
-
Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines.Pharmaceutics. 2023 May 12;15(5):1485. doi: 10.3390/pharmaceutics15051485. Pharmaceutics. 2023. PMID: 37242727 Free PMC article.
-
Advances in nano-based drug delivery systems for the management of cytokine influx-mediated inflammation in lung diseases.Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3695-3707. doi: 10.1007/s00210-023-02882-y. Epub 2023 Dec 11. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38078921 Review.
-
Research progress of N1-methyladenosine RNA modification in cancer.Cell Commun Signal. 2024 Jan 30;22(1):79. doi: 10.1186/s12964-023-01401-z. Cell Commun Signal. 2024. PMID: 38291517 Free PMC article. Review.
References
-
- Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
-
- Oudkerk M., Liu S., Heuvelmans M.A., Walter J.E., Field J.K. Lung cancer LDCT screening and mortality reduction-evidence, pitfalls and future perspectives. Nat Rev Clin Oncol. 2021;18(3):135–151. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials